Clinical Trial Update: The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical methotrexate for repigmentation in active non-segmental vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Drugs mentioned

• Methotrexate (topical) (Methotrexate)

Snippet

Sponsor: Nicolaus Copernicus University | Conditions: Non-segmental Vitiligo | Phase 3 | Status: COMPLETED